ASH Impact Series: Paul Richardson, MD - Examining the New FDA Approved Myeloma Drug Products



Paul Richardson, MD, discusses the new therapies for multiple myeloma that were approved by the FDA in November 2015, as well as his participation in the ASH/FDA Joint Symposium on Late-Breaking Drug Approvals at the 2015 ASH Annual Meeting. Visit for more on this topic and to watch other educational videos from ASH.


  • Paul Richardson, MD

back to top